Recipharm has launched Recipharm Analytical Solutions, a stand-alone service to support pharmaceutical companies with Quality Control (QC) and analytical requirements.  
Recipharm Analytical Solutions offers analytical services including method development, method validation, and stability program design and implementation.
  
The newly launched service leverages Recipharm’s experience and the scale of its laboratories to offer additional capacity to QC and analytical laboratories facing resource challenges.

The company opene a new analytical chemistry laboratory and additional stability walk-in chambers at its facility in Bengaluru, India. This Bengaluru lab, is the 9th addition to Recipharm’s global analytical solutions offering and became operational in October.  

Dr. Ramesh Jagadeesan, director of Analytical Development at Recipharm said, “Reducing time to market is a key consideration throughout every stage of drug development. By taking an innovative approach to analytical chemistry and using our expertise and capacity, we can improve efficiencies and reduce vital timelines for our customers. For example, worldwide, we are more than 160 analytical scientists that can perform analyses in parallel, share experience of all sorts of molecules and formulations and have the time to focus on finding solutions to customer challenges. Many customers place their full stability programs with us, thus offloading their own QC labs, giving them capacity to focus on core activities.”

Recipharm Analytical Solutions includes specialist expertise in analytical techniques including in vitro permeation testing/in vitro release testing methods (IVPT/IVRT), performance testing of inhalation products and extractables and leachables (E&L). Customers can access the service via various contracts, ranging from individual projects to fully dedicated laboratories.